user1asd34123asdsa

About user1asd34123asdsa

This author has not yet filled in any details.
So far user1asd34123asdsa has created 177 blog entries.

Vernakalant

2026-11-18T22:54:12+00:00

Trade Name: Brinavess Vernakalant is a Class III antiarrhythmic agent administered intravenously for the acute cardioversion of recent-onset atrial fibrillation lasting less than 7 days. It predominantly blocks potassium channels, classifying it as a Class III antiarrhythmic; however, it exhibits an electrophysiologically selective effect on the atrial myocardium. In 2010, its clinical administration was approved [...]

Vernakalant 2026-11-18T22:54:12+00:00

Ibutilide

2026-11-18T22:39:28+00:00

Ibutilide is a Class III antiarrhythmic agent available exclusively for intravenous administration. Indications It is indicated for use in the hospital setting for the cardioversion of recent-onset atrial fibrillation or atrial flutter. Pharmacological cardioversion (alternatively referred to as "chemical cardioversion") may be performed as an alternative to electrical cardioversion to restore normal sinus rhythm. However, [...]

Ibutilide 2026-11-18T22:39:28+00:00

Dronedarone

2026-11-18T22:39:00+00:00

Brand name: Multaq Dronedarone is an antiarrhythmic drug introduced into clinical practice in 2009. Structurally, the molecule closely resembles amiodarone. The absence of iodine is a structural feature that likely prevents some of the severe adverse effects associated with amiodarone. Its therapeutic indication is the prevention of recurrent episodes of atrial fibrillation and atrial flutter. [...]

Dronedarone 2026-11-18T22:39:00+00:00

Sotalol

2026-11-18T22:40:32+00:00

Indications Maintenance of sinus rhythm / Prevention of recurrence in patients with atrial fibrillation. It is less effective than amiodarone. Prevention of recurrent ventricular tachycardia. Prevention of supraventricular tachycardias. Adverse Effects / Adverse Drug Reactions (ADRs) Cardiovascular adverse effects include bradycardia, atrioventricular (AV) block, and QT interval prolongation, which may precipitate torsades de pointes (a [...]

Sotalol 2026-11-18T22:40:32+00:00

Amiodarone

2026-11-18T22:40:45+00:00

Trade Name: Angoron (available in Greece) Amiodarone constitutes one of the most critical and potent antiarrhythmic agents. In addition to being classified as a Class III antiarrhythmic, it exhibits electrophysiological characteristics of Class I, II, and IV agents, which likely accounts for its superior therapeutic efficacy. It can be administered both orally and intravenously. Amiodarone [...]

Amiodarone 2026-11-18T22:40:45+00:00

Ivabradine

2026-11-18T22:39:15+00:00

Brand name: Procoralan, Implicor (combination of metoprolol – ivabradine) Ivabradine is a pure heart rate-lowering agent that acts via the selective and specific inhibition of the sinoatrial node If current (the natural pacemaker of the heart). This current controls spontaneous diastolic depolarization within the sinoatrial node and regulates heart rate. It is indicated for the [...]

Ivabradine 2026-11-18T22:39:15+00:00

Beta-blockers (β-blockers)

2026-11-18T22:40:56+00:00

Beta-blockers constitute one of the most critical and frequently utilized therapeutic classes in cardiology. Their primary mechanism of action involves inhibiting the effects of adrenaline and noradrenaline on the myocardium, subsequently reducing both heart rate and arterial blood pressure. In the management of cardiac arrhythmias, their fundamental function is to decelerate electrical impulse transmission through [...]

Beta-blockers (β-blockers) 2026-11-18T22:40:56+00:00

Propafenone

2026-11-18T22:53:40+00:00

Commercial Trade Name: Rythmonorm (Note: This brand name is specific to the Greek pharmaceutical market) Propafenone, similar to flecainide, is a Class Ic antiarrhythmic agent. It is primarily indicated for supraventricular tachycardias, specifically atrial fibrillation, but may also be utilized in the management of ventricular arrhythmias. As a Class Ic antiarrhythmic, its administration is contraindicated [...]

Propafenone 2026-11-18T22:53:40+00:00

Flecainide

2026-11-18T22:53:50+00:00

Brand names: Flecarythm, Flecardia, Tambocor Flecainide is a class Ic antiarrhythmic agent administered both orally and intravenously. It is indicated for supraventricular arrhythmias—primarily atrial fibrillation—and ventricular arrhythmias. However, it is contraindicated in patients with ischemic heart failure and, by extension, in patients with structural heart disease. In the CAST clinical trial conducted in the late [...]

Flecainide 2026-11-18T22:53:50+00:00

Mexiletine

2026-11-18T22:39:58+00:00

Mexiletine is a Class Ib antiarrhythmic agent administered orally and indicated for patients with ventricular arrhythmias. Indications It is utilized for the management of patients with ventricular tachycardias, typically in combination with other pharmacological agents such as beta-blockers and amiodarone. Mexiletine is frequently used in patients with ischemic or dilated cardiomyopathy who experience recurrent episodes [...]

Mexiletine 2026-11-18T22:39:58+00:00